iOR Partners: Funding, Investors & Team (Oct 2026)

iOR Partners are pioneers of office-based cataract surgery (OBS) in ophthalmology. We work with leading ophthalmologists to transform their practices into OBS suites. iOR OBS suites are unique and separate from the traditional ASC, providing surgeons the ability to offer more personalized care in a safe and comfortable surgical environment. We provide each client with the time and guidance they deserve to develop a customized, comprehensive and ongoing office-based surgery program that adheres to the highest clinical and ethical standards. Our proprietary solution is turnkey and comes with a range of services including financial support for space build-out, capital equipment acquisition, staff training, administration, product supply and support services from concept to accreditation. Advantages of iOR Office-Based Surgery Suites - Seamlessly integrates clinic and surgery within the surgeon’s office - Utilizes highest level of patient safety - Provides a familiar and personalized premium surgical experience - Patient-friendly surgical facility reduces patient anxiety associated with ASC - Surgical staff works for the Surgeon - Combines clinic and surgery schedules - Increases patient capacity - Retains surgical revenues within the practice - Additional insurance reimbursements that traditionally would be paid to ASC iOR Partners is the only company dedicated to OBS suites and has established more than 100 office-based suites nationwide. With 100+ combined years of experience, our clients enjoy peace of mind when transforming their office and practice into an iOR office-based surgery suite.

iOR Partners has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in Oct 2024.

iOR Partners' most recent funding round on record is an undisclosed round of $2.0M, announced in Oct 2024.

FundedIQ lists Tony Burns (Founder) at iOR Partners.

iOR Partners is based in Kansas City, Missouri, United States.

iOR Partners is in the 11-50 employee band.

iOR Partners' latest round of $2.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.